We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
-0.99%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$62.4M
AUM Growth
-$14.7M
Cap. Flow
-$12.6M
Cap. Flow %
-20.11%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RNAC icon
Cartesian Therapeutics
RNAC
+$12.6M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
1
Fate Therapeutics
FATE
$286M
$49.5M 79.24%
569,889
– –
LYRA
2
DELISTED
LYRA THERAPEUTICS INC
LYRA
$8.84M 14.16%
22,017
– –
XFOR icon
3
X4 Pharmaceuticals
XFOR
$375M
$2.02M 3.24%
10,383
– –
ATYR
4
aTyr Pharma
ATYR
$47.6M
$637K 1.02%
130,572
– –
DARE icon
5
Dare Bioscience
DARE
$18.3M
$617K 0.99%
27,187
– –
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
$462K 0.74%
197,345
– –
PULM icon
7
Pulmatrix
PULM
$6.35M
$374K 0.6%
17,972
– –
RNAC icon
8
Cartesian Therapeutics
RNAC
$229M
– –
-92,449
Closed -$12.6M

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q2 2021 Portfolio in Review

As of Q2 2021, Polaris Venture Management Co V held 8 positions worth $62.4M, down 19% from $77.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V withdrew a net $12.6M in Q2 2021, closing 1 position. Its most notable exit was Cartesian Therapeutics, an estimated $12.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Polaris Venture Management Co V fully exited Cartesian Therapeutics in Q2 2021, selling an estimated $12.6M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $62.4M portfolio in Q2 2021.
  • Polaris Venture Management Co V opened 0 new positions and closed 1 in Q2 2021.
  • Polaris Venture Management Co V's portfolio value fell 19% quarter-over-quarter to $62.4M.

Based on Polaris Venture Management Co V's 13F filing for Q2 2021, filed 12 Aug 2021.